top of page

Clarence shortlisted for prestigious CIBSE Building Performance Awards

Angel Guard, the award-winning medical biotechnology company is looking to take away two awards at the CIBSE Building Performance Awards. Their remote water monitoring system Clarence has been shortlisted for both “Best Digital Innovation” and for “Product or Innovation of the Year – Wellbeing.”

The finalists have been chosen through an expert panel of industry judges with the winners being announced at a dinner hosted at the prestigious Park Plaza Hotel at Westminster Bridge, London, on Wednesday 1st March 2023.

The CIBSE Building Performance Awards (BPAs) are in their 16th year, having started in 2007, and serve to congratulate products and projects that showcase excellent engineering, and the people behind them. The awards themselves cover the depth and breadth of the UK, with each business being judged on actual, measured performance outcomes.

With Angel Guard being nominated for two BPAs, the company can expect national recognition up and down the United Kingdom. Through competing with established names within the industry, Angel Guard can only expect to see a strengthening in their brand reputation.

Angel Guard’s Managing Director Jonathan Waggott had this to say on the shortlisting, “We here at Angel Guard are simply overjoyed to have been shortlisted for two awards at this year’s CIBSE Awards, as there are plenty of organisations out there doing magnificent work every day. It is so important to have your work recognised and this is no exception, especially thanks to our Kickstart Scheme employees that are helping to push our company forward. Our mission is to improve people’s health and safety in buildings through our cutting-edge medical biotechnology products, and we couldn’t have asked for a much better way to start off 2023 than this.”

For more information on Angel Guard and their ground-breaking products, please visit or email

For more information on the Chartered Institution of Building Services Engineers, please visit

13 views0 comments


bottom of page